March, 18 2026 Wednesday 15:20 Hrs
Last update 11-9-2025
  • SENSEX :   76,759.50

  • Commodity broking firm in India688.66( 0.91%) 18-Mar-2026
top-arrow-market
Sensex 76796.46 725.62  (0.95) 18-Mar-2026
Previous Day Close
76070.84
Today's High/Low
High Low
  •  
  •  
77000.22 76187.92

Corporate News - Detailed News

Zydus receives USFDA approval for Bosentan 32 mg tablets
18-Feb-26   19:24 Hrs IST

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Bosentan tablets, oral suspension, 32 mg (USRLD: Tracleer' Tablets for Oral Suspension, 32 mg).

Bosentan 32 mg tablets for oral suspension are indicated for the treatment of Pulmonary Arterial Hypertension (PAH), specifically to improve exercise ability and reduce clinical worsening in children (aged 3 years and older) with idiopathic or congenital PAH. It is a dual endothelin receptor antagonist that lowers high blood pressure in the lungs, typically administered based on body weight.

Bosentan 32 mg tablets will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad.

Bosentan 32 mg tablets had annual sales of USD 9.3 mn in the United States (IQVIA MAT December 2025).

Powered by Capital Market - Live News

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.